86683309
Jul 4, 2015
Pharmaceutical preparations for epilepsy, seizures, muscle spasticity, and cancer; for the treatment of pain, nausea, anxiety, insomnia; for the treatment of the symptoms of terminal conditions, namely, dementia, dementia-related agitation and aggression, pain, nausea, anxiety, insomnia, appetite stimulation, amyotrophic lateral sclerosis, muscle spasticity, bronchodilation, saliva reduction, neuroprotection, AIDS, cancer, autoimmune conditions; for the treatment of glaucoma, positive status for human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), post-traumatic stress disorder (PTSD), amyotrophic lateral sclerosis (ALS), Crohn's disease, Parkinson's disease, multiple sclerosis; for the treatment of the symptoms of terminal and chronic conditions, namely, severe pain, debilitating nausea, appetite stimulation, debilitating arthritis, debilitating anxiety, debilitating depression, debilitating insomnia, debilitating spasticity, neuroprotection during brain injury, protection from neurodegeneration, debilitating dementia, debilitating migraines
Pharmaceuticals